6 research outputs found

    Rate ratio of PCV10 dosing schedule according to pneumococccal vaccine-type nasopharyngeal carriage.

    No full text
    §<p>Administered only for previously unvaccinated children who received the vaccine at 12 months of age or older.</p>†<p>Includes non-vaccine type carriage and non-carriage children.</p>‡<p>34 isolates missing Quellung reaction results: unvaccinated (n = 9), one catch-up dose (n = 8), 2p+0 (n = 6), 3p+0 (n = 11).</p

    Characteristics associated with unvaccinated and vaccinated children with PCV10.

    No full text
    †<p>Defined as children who did not receive any dose at all (n = 96) or 1 dose before 12 months of age (n = 124).</p>‡<p>Defined as children who received 2 (n = 365) or 3 (n = 397) doses before 12 months of age or 1 cacth up dose >12 months of age (n = 291).</p

    PCV10 effectiveness on pneumococcal vaccine-types carriage.

    No full text
    ‡<p>Administered only for children 12 months of age or older.</p>§<p>Adjusted for no. of children in household, mother’s schooling, day-care attendance, and age (as continuous variable).</p>†<p>Percentage based on results of multivariate analysis. Vaccine effectiveness: (1-RR)×100.</p

    Categories of exposure and outcome of interest considered for the estimation of rate ratio and vaccine effectiveness.

    No full text
    §<p>Administered only for children 12 months of age or older.</p>†<p>No culture for any other bacteria.</p><p>a+b+c+d  =  number of pneumococcal carriage, vaccine type and non-vaccine type.</p><p>c+d  =  number of unvaccinated children with pneumococcal carriage.</p><p>a+b  =  number of vaccinated children with pneumococcal carriage.</p
    corecore